Abbott Laboratories (ABT)vsPulmonx Corp (LUNG)
ABT
Abbott Laboratories
$91.07
+0.56%
HEALTHCARE · Cap: $151.49B
LUNG
Pulmonx Corp
$1.52
-5.59%
HEALTHCARE · Cap: $64.62M
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 50873% more annual revenue ($45.13B vs $88.55M). ABT leads profitability with a 13.9% profit margin vs -60.1%. ABT earns a higher WallStSmart Score of 56/100 (C).
ABT
Buy56
out of 100
Grade: C
LUNG
Avoid34
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-28.5%
Fair Value
$70.89
Current Price
$91.07
$20.18 premium
Intrinsic value data unavailable for LUNG.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Areas to Watch
Earnings declined 19.7%
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap. PEG of 1.30 suggests the stock is reasonably priced for its growth.
Bull Case : LUNG
The strongest argument for LUNG centers on Price/Book.
Bear Case : ABT
The primary concerns for ABT are EPS Growth.
Bear Case : LUNG
The primary concerns for LUNG are EPS Growth, Market Cap, Debt/Equity.
Key Dynamics to Monitor
ABT profiles as a value stock while LUNG is a turnaround play — different risk/reward profiles.
ABT carries more volatility with a beta of 0.65 — expect wider price swings.
ABT is growing revenue faster at 7.8% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Bottom Line
ABT scores higher overall (56/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Pulmonx Corp
HEALTHCARE · MEDICAL DEVICES · USA
Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. The company is headquartered in Redwood City, California.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?